Vol. 2 No. 7 (2022)
Editorial

Response to “Outdated Criteria for Drug Plan Reimbursement Obstruct Evidence-Based Care” Editorial in CMAJ

Published July 19, 2022

Key Messages

  • The authors of an editorial published in CMAJ made 3 recommendations to incorporate new evidence into health technology assessments after the initial regulatory approval stage: incorporate automatic times for review or regular reviews of evidence, accept non-sponsor submissions, and audit prescribing for nonadherence to restricted drugs.
  • This response to the editorial outlines existing and new evolving initiatives at CADTH to address each of the 3 recommendations.